Overnight for­tunes are be­ing made in biotech these days — and it's both en­cour­ag­ing and more than a lit­tle bit scary

Just to com­plete the last leg of a run­ning sto­ry I’ve been track­ing for a few weeks, Ole­ma $OL­MA has come through its IPO from the Thurs­day night pric­ing at $19 a share with a mar­ket cap just north of $2 bil­lion.

That leaves new­ly-named CEO Sean Bo­hen hold­ing a batch of 1,110,896 shares with a strike price of $4.82. As of Tues­day morn­ing, the stock is now trad­ing at $53.40, giv­ing him a port­fo­lio val­ue of $53.4 mil­lion. Not bad for some­one who was hired in Sep­tem­ber.

This article is for premium subscribers only

Upgrade to a premium subscription plan for unlimited access, and join our community of key biopharma players.

UPGRADE